Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

NCT04404764 · clinicaltrials.gov ↗

COMPLETED

Status

155

Enrollment

OTHER

Sponsor class

Conditions

Spinal Muscular Atrophy

Interventions

DRUG: Nusinersen Injectable Product

Sponsor

Hospital Israelita Albert Einstein

Collaborators

[object Object]